We are live on ! Find out more
CTA

Carillon Tower Advisers Portfolio holdings

AUM $16.4B
1-Year Est. Return 64.75%
This Fund
S&P 500
This Quarter Est. Return
+7.33%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
10 Year Est. Return
AUM
$12.7B
AUM Growth
-$159M
Cap. Flow
+$1.08B
Cap. Flow %
8.52%
Top 10 Hldgs %
10.09%
Holding
527
New
73
Increased
203
Reduced
139
Closed
69

Top Sells

Rank Stock Value
1
BURL icon
Burlington
BURL
+$70.3M
2
WCN
Waste Connections
WCN
+$61.3M
3
AYI icon
Acuity Brands
AYI
+$56.2M
4
JBLU icon
JetBlue
JBLU
+$54.3M
5
MLM icon
Martin Marietta Materials
MLM
+$53.3M

Sector Composition

Rank Sector Weight
1 Healthcare 19.28%
2 Technology 18.45%
3 Industrials 14.15%
4 Consumer Discretionary 14.07%
5 Financials 10.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OHI icon
201
Omega Healthcare
OHI
$15.4B
$22.5M 0.18%
726,048
+574,225
+378% +$16.4M
DAL icon
202
Delta Air Lines
DAL
$58.8B
$22M 0.17%
444,288
+7,164
+2% +$382K
HAIN icon
203
Hain Celestial
HAIN
$44.8M
$21.9M 0.17%
735,566
+47,677
+7% +$1.37M
LAMR icon
204
Lamar Advertising Co
LAMR
$16.5B
$21.6M 0.17%
316,773
+75,475
+31% +$5.06M
META icon
205
Meta Platforms (Facebook)
META
$1.51T
$21.6M 0.17%
+111,100
New +$20.1M
WAGE
206
DELISTED
WageWorks, Inc.
WAGE
$21.6M 0.17%
431,759
+82,570
+24% +$3.77M
NEM icon
207
Newmont
NEM
$96.4B
$21.5M 0.17%
571,075
+39,350
+7% +$1.55M
S
208
DELISTED
Sprint Corporation
S
$21.3M 0.17%
3,907,649
+274,599
+8% +$1.49M
HON icon
209
Honeywell
HON
$78.3B
$21M 0.17%
161,412
-2,766
-2% -$368K
HRB icon
210
H&R Block
HRB
$5.7B
$20.8M 0.16%
910,975
+410,925
+82% +$10.9M
AKBA icon
211
Akebia Therapeutics
AKBA
$341M
$20.6M 0.16%
2,060,804
PFE icon
212
Pfizer
PFE
$144B
$20.5M 0.16%
594,552
-10,187
-2% -$348K
STLD icon
213
Steel Dynamics
STLD
$37.5B
$20.2M 0.16%
439,900
-55,925
-11% -$2.65M
MRK icon
214
Merck
MRK
$326B
$20.2M 0.16%
348,783
+100,834
+41% +$5.69M
BWXT icon
215
BWX Technologies
BWXT
$15.5B
$20.1M 0.16%
321,900
+90,875
+39% +$6.04M
OGS icon
216
ONE Gas
OGS
$5.06B
$19.9M 0.16%
266,506
+105,825
+66% +$7.53M
GOOS
217
Canada Goose Holdings
GOOS
$903M
$19.7M 0.16%
335,135
CNK icon
218
Cinemark Holdings
CNK
$4.09B
$19.5M 0.15%
554,543
+60,761
+12% +$2.24M
CBAY
219
DELISTED
Cymabay Therapeutics
CBAY
$19.4M 0.15%
+1,447,270
New +$18.1M
CF icon
220
CF Industries
CF
$18.9B
$19.3M 0.15%
435,420
+30,200
+7% +$1.23M
LMT icon
221
Lockheed Martin
LMT
$134B
$19.3M 0.15%
65,253
-1,118
-2% -$361K
JNJ icon
222
Johnson & Johnson
JNJ
$643B
$18.7M 0.15%
154,401
-2,645
-2% -$330K
PANW icon
223
Palo Alto Networks
PANW
$260B
$18.6M 0.15%
544,050
+164,100
+43% +$5.47M
ROST icon
224
Ross Stores
ROST
$80.5B
$18.5M 0.15%
218,250
+33,925
+18% +$2.76M
MOH icon
225
Molina Healthcare
MOH
$10.5B
$18.5M 0.15%
188,819
+3,872
+2% +$337K

Similar funds

Carillon Tower Advisers's Q2 2018 Portfolio in Review

As of Q2 2018, Carillon Tower Advisers held 527 positions worth $12.7B, down 1.2% from $12.9B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Carillon Tower Advisers deployed $1.08B of net new capital in Q2 2018, opening 73 new positions and adding to 203 existing holdings. Its largest new stake was WW International: 726,252 shares worth $73.4M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Burlington, an estimated $70.3M trimmed.

  • Carillon Tower Advisers's largest Q2 2018 buy was WW International: 726,252 shares worth $73.4M.
  • Carillon Tower Advisers added most to Abiomed Inc in Q2 2018, an estimated $63.1M increase.
  • Carillon Tower Advisers's biggest Q2 2018 reduction was Burlington, cutting an estimated $70.3M.
  • Carillon Tower Advisers fully exited Acuity Brands in Q2 2018, selling an estimated $56.2M.
  • Carillon Tower Advisers's ten largest holdings make up 10% of its $12.7B portfolio in Q2 2018.
  • Carillon Tower Advisers opened 73 new positions and closed 69 in Q2 2018.
  • Carillon Tower Advisers's portfolio value fell 1.2% quarter-over-quarter to $12.7B.

Based on Carillon Tower Advisers's 13F filing for Q2 2018, filed 9 Aug 2018.